JOIN US

REFLEXION LUNCHEON AT AAPM

July 28, 2025 at 12:30 PM EDT | MEETING ROOM 152AB

RSVP

Join us for lunch on July 28th at 12:30 PM EDT to hear colleagues share their latest clinical experience with SCINTIX® biology-guided radiotherapy. Gain a deeper understanding of the expanding uses of SCINTIX therapy to treat multiple tumors from our panel of experts, including Murat Surucu, Ph.D. (Stanford University), Chenyang Shen, Ph.D. (University of Texas Southwestern), Tyler Watkins, Ph.D. (City of Hope), and Dave Carlson, Ph.D. (Yale New Haven Hospital). We are also excited to share, for the first time, details on the upcoming next-generation, RefleXion X2 platform with SCINTIX therapy.

SCINTIX THERAPY

SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated data throughout the entire treatment session to determine where to deliver radiotherapy.

DISCLOSURES

As a health care professional attendee of this event, you understand and agree that for purposes of complying with RefleXion’s mandatory transparency reporting obligations under the Patient Protection and Affordable Care Act (together with any regulations and official guidelines promulgated thereunder) and any applicable state reporting requirements, RefleXion may collect, aggregate and report any and all payments made pursuant to this event.